Uptake and efflux of intact antisense phosphorothioate deoxyoligonucleotide directed against angiotensin receptors in bovine adrenal cells

Neurochemistry International

Volumn 31, Issue 3, 1997, Pages 393-403

  Li, Bing ^a   Hughes, Jeffrey A ^b   Phillips, M Ian ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; NUCLEASE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; RIBONUCLEASE H;

ADRENAL CELL; ADRENAL CORTEX CELL; ANIMAL CELL; ARTICLE; CARDIOVASCULAR DISEASE; CATTLE; CELL NUCLEUS; CHROMATOGRAPHY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; GENETIC TRANSCRIPTION; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSPORT; THIN LAYER CHROMATOGRAPHY; TIME;

ADRENA; ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0030841036     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00109-X     Document Type: Article

References (32)

1. Bayever, E. and Iversen, P. (1994) Oligonucleotides in the treatment of leukemia. Hematol. Oncol. 12, 9-14.
2. Beltinger, C., Saragovi, H. U., Smith, R. M., LeSauteur, L., Shah, N., DeDionisio, L., Christensen, L., Raible, A., Jarett, L. and Gewirtz, A. M. (1995) Binding, uptake and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. clin. Invest. 95, 1814-1823.
3. Capaccioli, S., Pasquale, G. D., Mazzei, T. and Quattrone, A. (1993) Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem. biophys. Res. Commun. 197, 818-825.
4. Crooke, S. T. (1993) Progress toward olignucleotide therapeutics: pharmacodynamic properties. FASEB J. 7, 533-539.
5. Dagle, J., Weeks, D. and Walder, J. (1991) Pathways of degradation and mechanism of action antisense oligonucleotides in Xenopus laevis embryos. Antisense Res. Dev. 1, 11-20.
6. Elizabeth, L. R., Barry, F., Gesek, A. and Friedman, P. A. (1993) Introduction of antisense oligonucleotides into cells by permeabilization with streptolysin O. Biotechniques 15, 1016-1020.
7. Galabretta, B. (1991) Inhibition of protooncogene expression by antisense oligonucleotides. Biol. Therapeutic Implications Cancer Res. 51, 4505-4510.
8. 1 receptor mRNA and angiotensinogen mRNA in the brain of the spontaneously hypertensive rats reduces hypertension of neurogenic origin. Reg. Pep. 49, 167-174.
9. Hughes, J. A., Avrutskaya, A. V. and Juliano, R. L. (1994) Influence of base composition on membrane binding and cellular uptake of 10-mer phosphorothioate oligonucleotides in Chinese hamster ovary (CHRC5) cells. Antisense Res. Dev. 4, 211-215.
10. Iversen, P. L., Zhu, S., Meyer, A. and Zon, G. (1992) Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells. Antisense Res. Dev. 2, 211-222.
11. Kawasaki, A. M., Casper, M. D., Freier, S. M., Lesnik, E. A., Zounes, M. C., Cummins, L. L., Gonzlaez, C. and Cook, P. D. (1993) Uniformly modified 2′-deoxy-2′-fluoro phosphorothioate oligonucleotides as RNA targets. J. med. Chem. 36, 831-841.
12. Loke, S. L., Stein, D. A., Zhang, X. H., Mori, K., Nakanishi, M., Subasinghe, C., Cohen, J. S. and Neckers, L. M. (1989) Characterization of oligonucleotide transport into living cells. Proc. natn. Acad. Sci. U.S.A. 86, 3474.
13. Marti, G., Egan, W., Noguchi, P., Zon, G., Matsukura, M. and Broder, S. (1992) Oligodeoxyribonucleotide phosphorothioate fluxes and localization in hematopoietic cells. Antisense Res. Dev. 2, 27-39.
14. 1 oligonucleotide inhibits central angiotensin induced thirst and vasopressin. Reg. Pep. 54, 543-551.
15. Morishita, R., Gibbons, G. H., Ellison, K. E., Nakajima, M., von der Leyen, H., Zhang, L., Kaneda, Y., Ogihara, T. and Dzau, V. J. (1994) Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J. clin. Invest. 93, 1458-1464.
16. Nestle, F. O., Mitra, R. S., Bennett, C. F., Chan, H. and Nickoloff, N. J. (1994) Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes. J. invest. Dermatol. 103, 569-575.
17. Phillips, M. I. and Gyurko, R. (1995) In vivo applications of antisense oligonucleotides for peptide research. Reg. Pep. 59, 131-141.
18. Phillips, M. I., Wielbo, D. and Gyurko, R. (1994) Antisense inhibition of hypertension A new strategy for renin angiotensin candidate genes. Kidney Int. 46, 1554-1556.
19. Quattrone, A., Fibbig, Anichini E., Pucci, M., Zamperini, A., Capaccioli, S. and Del Rosso, M. (1995) Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of urokinase receptor gene expression. Cancer Res. 55, 90-95.
20. Ropert, C., Okruszek, A., Couvreur, P. and Malvy, C. (1994) Retroviral inhibition by antisense oligonucleotides determined by intracellular stability. Antisense Res. Dev. 4, 207-210.
21. Sands, H., Gorey Feret, L. J., Cocuzza, A. J., Hobbs, F. W., Chidester, D. and Trainor, G. L. (1994) Biodistribution and metabolism of internally 3H-labeled oligonuicleotides - I. Comparison of a phosphodiester and a phosphorothioate. Molec. Pharmac. 45, 932-943.
22. Sarah, B., Noonberg, S., Garovoy, M. R. and Hunt, A. C. (1993) Characteristics of oligonucleotide uptake in human keratinocyte cultures. J. invest. Dermatol. 101, 721-131.
23. Stein, C. A. and Cheng, Y.-C. (1993) Antisense oligonucleotides as therapeutic agents - is the bullet really magical?. Science 261, 1004-1012.
24. Stein, C. A., Tonkinson, J. L. and Yakubov, L. (1991) Phosphorothioate oligodeoxynucleotides antisense inhibitor of gene expression?. Pharmac. Ther. 52, 365-384.
25. Stein, C. A., Tonkinson, J. Z., Zhang, L.-M., Yakubov, L., Gervansoni, J., Taub, R. and Rotenberg, S. A. (1993) Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry 32, 4855.
26. Tam, R. C., Li, Y., Noonberg, S., Hwang, D. G., Lui, G., Hunt, C. A. and Garovoy, M. R. (1994) Biological availability and nuclease resistance extend the in vitro activity of a phosphorothioate-3'hydroxypropylamine oligonucleotide. Nucleic Acids Res. 25:22, 977-986.
27. Teichman-Weinberg, A., Littauer, U. Z. and Ginzburg, I. (1988) The inhibition of neurite outgrowth in PC12 cells by tublin antisense oligodexyribonucleotides. Gene 72, 297-307.
28. Temsamani, J., Kubert, M., Tang, J., Padmapriya, A. and Agrawal, S. (1994) Cellular uptake of oligonucleotide phosphorothioates and their analogs. Antisense Res. Dev. 4, 3542.
29. Wickstrom, E. (1986) Oligodeoxynucleotide stability in subcellular extracts and culture media. J. biochem. biophys. Meth. 13, 97-102.
30. Yakubov, L. A., Deeva, E. A., Zarytova, V. F., Ivanova, E. M., Ryte, A. S., Yurchenko, L. V. and Vlassov, W. (1989) Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. natn. Acad. Sci. U.S.A. 86, 6454.
31. Zhao, Q., Matson, S., Herrera, C. J., Fisher, E., Yu, H. and Krieg, A. M. (1993) Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3, 53-66.
32. Zhao, Q., Waldschmidt, T., Fisher, E., Herrera, C. J. and Krieg, A. M. (1994) Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors. Blood 84, 3660-3666.